A lncRNA down-regulated in liver cancer stem cells (lncDILC) has been shown to interfere with NF-κB-mediated IL-6 expression via inhibiting STAT3 signaling, and thus has prognostic value for patients with HCC (Wang et al., 2016). This evidence concerns the gene STAT3 and hepatocellular carcinoma.